GeneDx’s Post

#BioFuture2024 is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of therapeutics and digital health. Here's a glimpse into the important panel discussions, networking, and company presentations that you can experience. Register here to join us this Oct 28-30 >> https://bit.ly/3mF5BO4

Last week, Ivana Magovcevic-Liebisch, PhD, JD moderated a panel discussion where industry leaders shared their perspectives on designing and running clinical trials in the ever-changing landscape of modern drug development #Convergence2024

Thank you to everyone who joined us for our webinar, "Adapting Clinical Strategies for Rapid Response," on November 27. The session featured valuable insights from industry experts on navigating clinical trials during challenging times, covering topics like Risk Mitigation, Operational Challenges, Crisis Response, Trial Continuity, Outsourcing Partnerships, Trial Logistics, Geopolitical Impact. If we missed you, or if you would like to revisit the discussion, the recording is now available: https://ow.ly/qppr50UjHu3 Let’s continue the conversation on building resilience in clinical trials to deliver better outcomes in uncertain environments. Dr. Nancy Shulman, MD, Dr. Ivan Vyshnyvetskyy, Dr. David Ng, Catalin Crai, Adrian Karrer #ClinicalTrials #Biotech #Novotech

📊 Market Movers Update 📊 The stock market today displays significant fluctuations with contrasting performances from market leaders that have caught the eye of investors globally. Led strong by technology services, Innodata Inc. and Sezzle Inc. marked considerable gains, while the consumer services sector too had a shining star with Sonder Holdings Inc. However, there were setbacks faced by Evolent Health, Inc., Chanson International Holding, and Revance Therapeutics, Inc. 💡 Key Insights: ➡️ Outperformers in Technology services sector, Innodata Inc. and Sezzle Inc., ended the day with a noteworthy increase. ➡️ Likewise, in consumer services, Sonder Holdings Inc. posted a significant increment. ➡️ However, it was a challenging scene for Evolent Health, Inc. in commercial services, Chanson International Holding in consumer non-durables, and Revance Therapeutics, Inc in health technology. These current trends reflect the vibrant nature of the market and the potential investment opportunities it holds. For more information about this Post please visit: https://lnkd.in/eVhY5Vug Stay informed, stay ahead. 🚀 #MarketUpdate #Trading #Investment #StockMarket #Technology #ConsumerServices #HealthTech Content shared by Zimtra is for informational purposes only, and not trading advice. Always do your own research before making any investment., Click https://lnkd.in/dVH_nnRE for more information.

Why do Adaptive Trials Matter? ⚡ They enable rapid, data-driven decisions, streamlining the identification of effective treatments and saving resources by focusing on what works best. 🛡️ They allow real-time adjustments to dosing or patient groups, ensuring participants receive the safest and most effective care throughout the trial. 🎯 Especially in complex therapeutic areas, adaptive trials improve success rates, bringing essential treatments to patients more efficiently. At Veristat, we design and navigate the complexities of adaptive trials, ensuring your study is scientifically robust and regulatory compliant. Our mission? To help you deliver life-saving treatments faster. Find out more: https://lnkd.in/gg-BN9xK #ClinicalTrials #AdaptiveDesigns #Veristat #ClinicalResearch #Innovation #BetterOutcomes #PatientSafety

Cognizant’s Bryan Hill will join an esteemed panel of global industry experts at DIA, comprised of executives from Medable and BMS. The panel will discuss the future of DCT, including the significance of a unified platform and the current and future best practices in data collection and analysis. Join the session to hear them address key themes that are core to setting and defining a digital and decentralized drug development strategy: scale, inclusion, speed, adoption, and cost. https://lnkd.in/exA5UQs

Unlock the power of data with these 5 quick tips shared by our wonderful panel, Anne Post of Xakia, Chuck Kable of Innovative Renal Care, and Jennifer Ryan of U.S. Venture, Inc.. Want to join us for one of our upcoming webinars? Register today: https://lnkd.in/dfr4c7FX #InHouseCounsel #GeneralCounsel #LawyerLife #InHouseConnect #LawyersOfLinkedin #LegalMarketing

Game changing! Please reach out to learn more about how our new Site Profile & Overview Tool is enabling study teams to pinpoint anomalies and translate data insights into actionable next steps, ultimately, reducing the number of site visits and costs and therefore, improving your carbon footprint! #ClinicalResearch #ClinicalTrials #DataQuality

I recently had the opportunity to discuss how hospitals can leverage the power of analytics to enhance their Diversion Programs. In todays healthcare landscape, the integration of AI tools is becoming a necessity. Whether you are in healthcare administration, informatics, or on the front lines or patient care, understanding how to effectively utilize and leverage date is crucial to making informed decisions that ultimately improve the quality of care we can provide. Check out the article!

Want to advance your life sciences clinical research with secure, de-identified, precisely linked data? Watch the video on next-gen tokenization to unlock the potential of de-identified data and improve patient outcomes. Video Link: https://splr.io/6040WMPrG #lifesciences #clinicalresearch #tokenization #patientoutcomes